These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12675669)

  • 1. The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study.
    Bingham E; Hopkins D; Pernet A; Reid H; Macdonald IA; Amiel SA
    Diabet Med; 2003 Mar; 20(3):231-7. PubMed ID: 12675669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
    Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.
    Bijlstra PJ; Lutterman JA; Russel FG; Thien T; Smits P
    Diabetologia; 1996 Sep; 39(9):1083-90. PubMed ID: 8877293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state.
    Fanelli CG; Pampanelli S; Porcellati F; Bartocci L; Scionti L; Rossetti P; Bolli GB
    Diabetologia; 2003 Jan; 46(1):53-64. PubMed ID: 12637983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
    Fabricius TW; Verhulst CEM; Kristensen PL; Holst JJ; Tack CJ; McCrimmon RJ; Heller SR; Evans ML; de Galan BE; Pedersen-Bjergaard U;
    Acta Diabetol; 2024 May; 61(5):623-633. PubMed ID: 38376580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses.
    Evans ML; McCrimmon RJ; Flanagan DE; Keshavarz T; Fan X; McNay EC; Jacob RJ; Sherwin RS
    Diabetes; 2004 Oct; 53(10):2542-51. PubMed ID: 15448082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat.
    Clapham JC; Trail BK; Hamilton TC
    Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.
    Snorgaard O; Lassen LH; Rosenfalck AM; Binder C
    J Intern Med; 1991 Apr; 229(4):343-50. PubMed ID: 2026987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.
    Fanelli C; Di Vincenzo A; Modarelli F; Lepore M; Ciofetta M; Epifano L; Pampanelli S; Brunetti P; Bolli GB
    Diabetologia; 1993 Nov; 36(11):1191-7. PubMed ID: 8270135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM.
    Maran A; Lomas J; Macdonald IA; Amiel SA
    Diabetologia; 1995 Dec; 38(12):1412-8. PubMed ID: 8786014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride.
    Bijlstra PJ; Russel FG; Thien T; Lutterman JA; Smits P
    Horm Metab Res; 1996 Sep; 28(9):512-6. PubMed ID: 8911989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.